CIDEA and fatty liver disease: Moreover, supplementation was able to downregulate genes, such as CIDEA (cell death-inducing DFFA-like effector A) and Apoa4 (apolipoprotein A-IV), which are known to be related to hepatic steatosis and inflammation [147].